Cargando…

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies

OBJECTIVES: The kynurenine (KYN) pathway has been attracting attention as a relevant pathway in schizophrenia (SZ), bipolar disorder (BD), and major depressive disorder (MDD). We conducted a systematic review and meta-analysis of studies examining KYN pathway metabolites from cerebrospinal fluid (CS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inam, Mehmet Enes, Fernandes, Brisa S., Salagre, Estela, Grande, Iria, Vieta, Eduard, Quevedo, João, Zhao, Zhongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668321/ https://www.ncbi.nlm.nih.gov/pubmed/37127280 http://dx.doi.org/10.47626/1516-4446-2022-2973

Ejemplares similares

The kynurenine pathway in schizophrenia, bipolar disorder, and major depressive disorder: a systematic review and meta-analysis of cerebrospinal fluid studies
por: Salagre, E., et al.
Publicado: (2023)

The kynurenine pathway in Alzheimer’s disease: a meta-analysis of central and peripheral levels
por: Fernandes, Brisa S., et al.
Publicado: (2023)

Risk Calculators in Bipolar Disorder: A Systematic Review
por: Silva Ribeiro, Joana, et al.
Publicado: (2020)

Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
por: Solé, Brisa, et al.
Publicado: (2017)

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
por: Salagre, Estela, et al.
Publicado: (2018)

Electroconvulsive therapy following incident bipolar disorder: When, how, and for whom?
por: Salagre, Estela, et al.
Publicado: (2022)

Cognitive Remediation Interventions in Schizoaffective Disorder: A Systematic Review
por: Lopez-Fernandez, Ester, et al.
Publicado: (2018)

Clinical predictors of kynurenine pathway aberrations in schizophrenia and bipolar disorder
por: Skorobogatov, K., et al.
Publicado: (2022)

Lifetime Psychotic Symptoms, Subthreshold Depression and Cognitive Impairment as Barriers to Functional Recovery in Patients with Bipolar Disorder
por: Bonnín, Caterina Mar, et al.
Publicado: (2019)

Functional Remediation for Bipolar Disorder
por: Martínez-Arán, Anabel, et al.
Publicado: (2011)

Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder
por: Skorobogatov, Katrien, et al.
Publicado: (2023)

Physical health in affective disorders: a narrative review of the literature
por: Colomer, Lluc, et al.
Publicado: (2020)

Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia
por: Culpepper, Larry, et al.
Publicado: (2022)

Microscopic Particles in Two Fractions of Fresh Cerebrospinal Fluid in Twins with Schizophrenia or Bipolar Disorder and in Healthy Controls
por: Johansson, Viktoria, et al.
Publicado: (2012)

Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
por: Bortolato, Beatrice, et al.
Publicado: (2015)

Involvement of Kynurenine Metabolism in Bipolar Disorder: An Updated Review
por: Zhang, Peifen, et al.
Publicado: (2021)

Cerebrospinal fluid proteomic study of two bipolar disorder cohorts
por: Isgren, Anniella, et al.
Publicado: (2022)

Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder
por: Bonnín, Caterina del Mar, et al.
Publicado: (2019)

A Review of Asenapine in the Treatment of Bipolar Disorder
por: Vieta, Eduard, et al.
Publicado: (2017)

Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder
por: Oliva, Vincenzo, et al.
Publicado: (2022)

Staging in bipolar disorder: one step closer to precision psychiatry
por: Fernandes, Brisa S., et al.
Publicado: (2017)

Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls
por: Pålsson, Erik, et al.
Publicado: (2017)

Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
por: Dodd, Seetal, et al.
Publicado: (2015)

The Role of BDNF as a Mediator of Neuroplasticity in Bipolar Disorder
por: Grande, Iria, et al.
Publicado: (2010)

Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder
por: Birner, Armin, et al.
Publicado: (2017)

Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates
por: Balanzá-Martínez, Vicent, et al.
Publicado: (2015)

Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2009)

Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2010)

Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2011)

Kynurenine Pathway Metabolites in the Blood and Cerebrospinal Fluid Are Associated with Human Aging
por: Solvang, Stein-Erik H., et al.
Publicado: (2022)

Onset and relapse prevention of bipolar disorders
por: Vieta, E.
Publicado: (2023)

The Kynurenine Pathway and Bipolar Disorder: Intersection of the Monoaminergic and Glutamatergic Systems and Immune Response
por: Kadriu, Bashkim, et al.
Publicado: (2019)

Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder
por: Amann, B. L., et al.
Publicado: (2015)

4.4 INTERNET-BASED INTERVENTIONS FOR BIPOLAR DISORDER
por: Hidalgo-Mazzei, Diego, et al.
Publicado: (2018)

Longer illness duration is associated with greater individual variability in functional brain activity in Schizophrenia, but not bipolar disorder
por: Gallucci, Julia, et al.
Publicado: (2022)

Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies
por: Fernandes, Brisa S., et al.
Publicado: (2015)

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2020)

Pareidolia in Schizophrenia and Bipolar Disorder
por: Abo Hamza, Eid G., et al.
Publicado: (2021)

Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease
por: Rodrigues, Filipe B., et al.
Publicado: (2021)

Precision in bipolar disorders
por: Grande, I.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ibniv40j4vcrmk263a4d4b63e4